Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with Type 2 diabetes

Medicine and Dentistry

• Serum 100%
• Patient with Type 2 Diabetes 87%
• Inpatient 62%
• Maturity Onset Diabetes of the Young 37%
• Monocyte 37%
• Receptor 25%
• Age 25%
• Gene Expression 25%
• Advanced Glycation End-Product 25%
• Real Time Polymerase Chain Reaction 12%
• Complications of Diabetes Mellitus 12%
• Enzyme Linked Immunosorbent Assay 12%
• Pathogenesis 12%
• Combination Therapy 12%
• Homeostatic Model Assessment 12%
• Ligand 12%
• Association 12%
• Patient 12%
• Man 12%

Biochemistry, Genetics and Molecular Biology

• Blood Level 37%
• Monocyte 37%
• Gene Expression 25%
• Advanced Glycation End-Product 25%
• RAGE (Gene) 25%
• Age 25%
• Electric Potential 12%
• Homeostasis 12%
• Real-Time Polymerase Chain Reaction 12%
• Insulin Resistance 12%
• Animal Experiment 12%
• RAGE (Receptor) 12%
• Association 12%
• Lysozyme 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 37%
• Receptor 25%
• Advanced Glycation End Product 25%
• Pathogenesis 12%
• Diabetes Mellitus 12%
• Ligand 12%
• Diabetic Complication 12%